BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22561451)

  • 1. Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells.
    Ichiki T; Miyazaki R; Kamiharaguchi A; Hashimoto T; Matsuura H; Kitamoto S; Tokunou T; Sunagawa K
    Regul Pept; 2012 Aug; 177(1-3):35-9. PubMed ID: 22561451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
    Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
    J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
    Miyazaki R; Ichiki T; Hashimoto T; Inanaga K; Imayama I; Sadoshima J; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1263-9. PubMed ID: 18420994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells.
    Gomez Sandoval YH; Lévesque LO; Anand-Srivastava MB
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1037-45. PubMed ID: 20029540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis.
    Inanaga K; Ichiki T; Matsuura H; Miyazaki R; Hashimoto T; Takeda K; Sunagawa K
    Hypertens Res; 2009 Jun; 32(6):466-71. PubMed ID: 19373235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan inhibits STAT1 activation and protects human glomerular mesangial cells from angiotensin II induced premature senescence.
    Jiao S; Zheng X; Yang X; Zhang J; Wang L
    Can J Physiol Pharmacol; 2012 Jan; 90(1):89-98. PubMed ID: 22217266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
    Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.
    Hayabuchi Y; Nakaya Y; Yasui S; Mawatari K; Mori K; Suzuki M; Kagami S
    J Mol Cell Cardiol; 2006 Dec; 41(6):972-9. PubMed ID: 16919291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced overexpression of sirtuin 1 contributes to enhanced expression of Giα proteins and hyperproliferation of vascular smooth muscle cells.
    Hossain E; Li Y; Anand-Srivastava MB
    Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H496-H508. PubMed ID: 34270373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II induced contraction of rat and human small intestinal wall musculature in vitro.
    Ewert S; Spak E; Olbers T; Johnsson E; Edebo A; Fändriks L
    Acta Physiol (Oxf); 2006 Sep; 188(1):33-40. PubMed ID: 16911251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change of telomere length in angiotensin II-induced human glomerular mesangial cell senescence and the protective role of losartan.
    Feng X; Wang L; Li Y
    Mol Med Rep; 2011; 4(2):255-60. PubMed ID: 21468560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor.
    Lin YJ; Kwok CF; Juan CC; Hsu YP; Shih KC; Chen CC; Ho LT
    Biochem Biophys Res Commun; 2014 Aug; 451(2):263-9. PubMed ID: 25088996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
    Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
    Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ginsenoside Rg1 on the senescence of vascular smooth muscle cells.
    Li SG; Yan MZ; Zhang D; Ye M; Deng JJ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells.
    Louis S; Saward L; Zahradka P
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H746-56. PubMed ID: 21622819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
    Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
    Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.